Onkologie. 2008:2(4):226-228

FOLLOW UP IN PATIENTS WITH DISTANT METASTASES OF COLORECTAL CARCINOMA INTO THE LIVER

Luboš Holubec2, Ondřej Topolčan2, Jindřich Fínek1, Vladislav Třeška1, Václav Liška2
1 Chirurgická klinika FN Plzeň
2 Radioterapeutické a onkologické oddělení FN, Plzeň

The aim of review article is to inform the readers with current problems of follow up of patients with metastases of colorectal carcinoma from a oncologist perspective.

Keywords: Key words: colorectal cancer, liver metastases, follow up.

Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holubec L, Topolčan O, Fínek J, Třeška V, Liška V. FOLLOW UP IN PATIENTS WITH DISTANT METASTASES OF COLORECTAL CARCINOMA INTO THE LIVER. Onkologie. 2008;2(4):226-228.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Nordlinger B, Benoist S. Liver metastases from colorectal cancer: a multidisciplinary approach is necessary. Bull Acad Natl Med. 2008 Jan; 192(1): 33-43. Go to original source... Go to PubMed...
    2. Yang YY, Fleshman JW, Strasberg SM. Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases. J Gastrointest Surg. 2007 Jul; 11(7): 929-944. Go to original source... Go to PubMed...
    3. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008 May; 134(5): 1296-1310. Go to original source... Go to PubMed...
    4. Lim E, Thomson BN, Heinze S, et al. Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer. ANZ J Surg. 2007 Nov; 77(11): 941-947. Go to original source... Go to PubMed...
    5. Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 2003; 8(5): 425-437. Go to original source... Go to PubMed...
    6. Gruenberger B, Tamandl D, Schueller J, et al. Capecitabine and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol. 2008 Apr 10; 26(11): 1830-1835. Go to original source... Go to PubMed...
    7. Kandutsch S, Klinger M, Hacker S, et al. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol. 2008 Nov; 34(11): 1231-1236. Go to original source... Go to PubMed...
    8. Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 2005; 10: 250-261. Go to original source... Go to PubMed...
    9. Van Cutsen E, Nowacki M, Lang I. Randomized phase III study of irinotecan and FUFA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial. J Clin Oncol 2007; 25 (Suppl 18): Abstr 4000. Go to original source...
    10. Nordlinger B, Sorbye H, Glimelius B, et al. EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008 Mar 22; 371(9617): 1007-1016. Go to original source... Go to PubMed...
    11. Kreuzberg B. Radiodiagnostika kolorektálního karcinomu. In: Holubec L sen. a kolektiv. Kolorektální karcinom. Současné možnosti diagnostiky a léčby. Praha: Grada Publishing, a.s., 2004; 79-88.
    12. Koželuhová J, Holubec L. Endoskopické vyšetření tlustého střeva a rekta. In: Holubec L sen. a kolektiv. Kolorektální karcinom. Současné možnosti diagnostiky a léčby. Praha: Grada Publishing, a.s., 2004; 89-96.
    13. Emura F, Saito Y, Ikematsu H. Narrow-band imaging optical chromocolonoscopy: advantages and limitations. World J Gastroenterol. 2008 Aug 21; 14(31): 4867-4872. Go to original source... Go to PubMed...
    14. Sohns C, Heuser M, Sossalla S, et al. Current role and future potential of computed tomographic colonography for colorectal polyp detection and colon cancer screening-incidental findings. Clin Imaging. 2008 Jul-Aug; 32(4): 280-286. Go to original source... Go to PubMed...
    15. Vikram R, Iyer RB. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging. 2008 Oct 4; 8 Suppl A: S46-S51. Go to original source... Go to PubMed...
    16. Duffy MJ, van Dalen A, Haglund C, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007 Jun; 43(9): 1348-1360. Go to original source... Go to PubMed...
    17. Bast RC Jr, Ravdin P, Hayes DF, et al. American Society of Clinical Oncology Tumor Markers Expert Panel. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001 Mar 15; 19(6): 1865-1878. Go to original source... Go to PubMed...
    18. Liška V, Třeška V, Holubec L, et al. Recurrence of colorectal liver metastases after surgical treatment: multifactorial study. Hepatogastroenterology. 2007 Sep; 54(78): 1741-1744. Go to PubMed...
    19. Liška V, Holubec L Jr, Třeška V, et al. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases. Anticancer Res. 2007 Jul-Aug; 27(4C): 2861-2864. Go to PubMed...
    20. Liška V, Holubec L, Třeška V, et al. Tumor markers as useful predictors of survival rate after exploratory laparotomy for liver malignancies. Anticancer Res. 2007 Jul-Aug; 27(4A): 1887-1891. Go to PubMed...
    21. Holubec L, Topolčan O, Fínek J, et al. Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma. Anticancer Research, 2005; 25(3A): 1597-1602. Go to PubMed...
    22. Holubec L, Topolčan O, Fínek J, et al. Cell adhesive markers in the process of metastasising colorectal carcinoma. In Lee I. Swenson-editor. Progress in tumor marker research. New York, Nova Science Publishing, Inc., 2007; 166-172.
    23. Levý M, Visokai V, Lipská L, et al. Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma. 2008; 55(2): 138-142. Go to PubMed...
    24. Topolčan O, Holubec L jr. The role of thymidine kinase in cancer diseases. Expert Opinion on Medical Diagnostics, 2008; 2(2): 129-141. Go to original source... Go to PubMed...
    25. Abad A, Figueras J, Valls C, et al. Guidelines for the detection and treatment of liver metastases of colorectal cancer. Clin Transl Oncol. 2007 Nov; 9(11): 723-730. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.